Statins and prevention of atrial fibrillation in patients with heart failure

International Journal of Cardiology

Volumn 135, Issue 3, 2009, Pages

  Liu, Tong ^a   Li, Guangping ^a   Korantzopoulos, Panagiotis ^b   Goudevenos, John A ^b  

^a Second Affiliated Hospital   (China)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Atrial fibrillation; Atrial remodeling; Heart failure; Inflammation; Oxidative stress; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ION CHANNEL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; EPIDEMIC; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ATRIAL FIBRILLATION; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67349093533     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.042     Document Type: Article

References (20)

1. Abi Nasr I., Mansencal N., and Dubourg O. Management of atrial fibrillation in heart failure in the elderly. Int J Cardiol 125 (2008) 178-182
2. Hanna I.R., Heeke B., Bush H., et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 3 (2006) 881-886
3. Dickinson M.G., Hellkamp A.S., Ip J.H., et al. Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HEFT. Heart Rhythm 3 Suppl (2006) S49
4. Adabag A.S., Nelson D.B., and Bloomfield H.E. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure. Am Heart J 154 (2007) 1140-1145
5. Kostapanos M.S., Liberopoulos E.N., Goudevenos J.A., Mikhailidis D.P., and Elisaf M.S. Do statins have an antiarrhythmic activity?. Cardiovasc Res 75 (2007) 10-20
6. Savelieva I., and Camm J. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat Clin Pract Cardiovasc Med 5 (2008) 30-41
7. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
8. Tousoulis D., Charakida M., Stefanadi E., Siasos G., Latsios G., and Stefanadis C. Statins in heart failure. Beyond the lipid lowering effect. Int J Cardiol 115 (2007) 144-150
9. Shanes J.G., Minadeo K.N., Moret A., Groner M., and Tabaie S.A. Statin therapy in heart failure: prognostic effects and potential mechanisms. Am Heart J 154 (2007) 617-623
10. Liu T., Li L., Korantzopoulos P., Liu E., and Li G. Statin use and development of atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol 126 (2008) 160-170
11. Shiroshita-Takeshita A., Brundel B.J., Burstein B., et al. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res 74 (2007) 75-84
12. Okazaki H., Minamino T., Wakeno M., et al. Statin prevents structural and electrical atrial remodeling in rat hypertensive heart failure induced by chronic inhibition of NO synthesis. Circulation 116 Suppl II (2007) 140
13. Korantzopoulos P., Galaris D., Papaioannides D., and Kokkoris S. C-reactive protein and oxidative stress in atrial fibrillation. Int J Cardiol 88 (2003) 103-104
14. Korantzopoulos P., Kolettis T.M., Galaris D., and Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007) 135-143
15. Liu T., Li G., Li L., and Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49 (2007) 1642-1648
16. Korantzopoulos P., Galaris D., Papaioannides D., and Siogas K. The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Med Sci Monit 9 (2003) RA120-RA125
17. Liu T., Li G.P., and Huang T.G. Anti-inflammatory therapies in atrial fibrillation. Int J Cardiol 104 (2005) 359-360
18. Musco S., Conway E.L., and Kowey P.R. Drug therapy for atrial fibrillation. Med Clin North Am 92 (2008) 121-141
19. Korantzopoulos P., and Kokkoris S. The antioxidant effects of statins may extend beyond atherosclerosis: potential benefits for atrial fibrillation and heart failure. Atherosclerosis 175 (2004) 187
20. Celik T., Iyisoy A., Dogru M.T., and Isik E. Statin use in chronic heart failure: waiting for the results of large prospective outcome trials. Int J Cardiol 132 (2009) 122-124